Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (151-160 of 723) with videos related to

Pageof 73
Sort By:
Molecular and Cellular Endocrinology|December 1, 1989
Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dogD Lacoste, D Dubé, A Bélanger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 27, 1998
Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the ratA Sourla, M Flamand, A Bélanger, et al.
General and Comparative Endocrinology|December 1, 1972
Organ distribution of thyrotropin-releasing hormoneA Dupont, F Labrie, G Pelletier, et al.
Journal of Andrology|May 1, 1986
Radioautographic localization of beta-adrenergic receptors in the rat ventral prostateD Dubé, P Poyet, G Pelletier, et al.
British Medical Journal (Clinical Research Ed.)|November 1, 1986
Combination therapy in prostate cancerF Labrie, A Dupont, J Emond, et al.
The American Journal of Physiology|March 1, 1990
Model of the distribution and metabolism of a GnRH superagonist in dogsD Lacoste, B Candas, M Normand, et al.
L'Union Medicale Du Canada|April 1, 1986
[Use of bone scintigraphy in the evaluation of bone involvement by prostatic cancer treated with a LHRH-antiandrogen combination]Y Lacourcière, A Dupont, M Giguère, et al.
Regulatory Peptides|January 1, 1983
Distribution of corticotropin-releasing factor in ovine brain determined by radioimmunoassayJ Côté, G Lefèvre, F Labrie, et al.
Science (New York, N.Y.)|June 9, 1978
Potent antidopaminergic activity of estradiol at the pituitary level on prolactin releaseV Raymond, M Beaulieu, F Labrie, et al.
Endocrinology|January 1, 1993
Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cellsP Couture, C Thériault, J Simard, et al.
Pageof 73

Showing results (151-160 of 723) with videos related to

Sort By:
Pageof 73
Molecular and Cellular Endocrinology|December 1, 1989
Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dogD Lacoste, D Dubé, A Bélanger, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 27, 1998
Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the ratA Sourla, M Flamand, A Bélanger, et al.
General and Comparative Endocrinology|December 1, 1972
Organ distribution of thyrotropin-releasing hormoneA Dupont, F Labrie, G Pelletier, et al.
Journal of Andrology|May 1, 1986
Radioautographic localization of beta-adrenergic receptors in the rat ventral prostateD Dubé, P Poyet, G Pelletier, et al.
British Medical Journal (Clinical Research Ed.)|November 1, 1986
Combination therapy in prostate cancerF Labrie, A Dupont, J Emond, et al.
The American Journal of Physiology|March 1, 1990
Model of the distribution and metabolism of a GnRH superagonist in dogsD Lacoste, B Candas, M Normand, et al.
L'Union Medicale Du Canada|April 1, 1986
[Use of bone scintigraphy in the evaluation of bone involvement by prostatic cancer treated with a LHRH-antiandrogen combination]Y Lacourcière, A Dupont, M Giguère, et al.
Regulatory Peptides|January 1, 1983
Distribution of corticotropin-releasing factor in ovine brain determined by radioimmunoassayJ Côté, G Lefèvre, F Labrie, et al.
Science (New York, N.Y.)|June 9, 1978
Potent antidopaminergic activity of estradiol at the pituitary level on prolactin releaseV Raymond, M Beaulieu, F Labrie, et al.
Endocrinology|January 1, 1993
Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cellsP Couture, C Thériault, J Simard, et al.
Pageof 73